| Old Articles: <Older 5381-5390 Newer> |
 |
The Motley Fool January 26, 2009 Brian Orelli |
Which One of These Is Not Like the Other? Bristol-Myers and Eli Lilly run into some comparability issues.  |
Entrepreneur February 2009 Dennis Romero |
DNA Testing: A Growth Market The barriers to entry are daunting, but the DNA market provides opportunities.  |
The Motley Fool January 23, 2009 Brian Orelli |
Intuitive Surgical Is Taking Cues From Warren Buffett Even with the paltry projected growth predicted in the short-term, Intuitive Surgical looks like a good long-term investment.  |
The Motley Fool January 23, 2009 Robert Steyer |
BAX to the Future After minding its own business, Baxter International starts thinking about acquisitions again.  |
The Motley Fool January 23, 2009 Brian Orelli |
Wyeth Isn't Cheap Enough for Pfizer The Wall Street Journal reports that Pfizer is in talks to acquire Wyeth for $60 billion or more. Should they do it?  |
The Motley Fool January 22, 2009 Brian Orelli |
Abbott Labs Thumbs Nose at Recession On a GAAP basis, Abbott Labs fourth-quarter earnings per share were up a whopping 27%, and even better, the double-digit increases don't look like they're going to stop anytime soon.  |
The Motley Fool January 21, 2009 Brian Orelli |
Pharma Foe Speaks Up for Investors Some good ideas for President Obama's new Food and Drug Administration chief that would benefit investors in drug companies.  |
The Motley Fool January 21, 2009 Brian Orelli |
A Copycat on the Prowl Teva Pharmaceutical announces it is partnering with Lonza to develop generic versions of biologics, called biosimilars, or follow-on biologics.  |
The Motley Fool January 20, 2009 Brian Orelli |
Johnson & Johnson Nimble ... for Now The health-care giant reports increasing earnings, despite falling revenue.  |
The Motley Fool January 20, 2009 Anders Bylund |
Foolish Forecast: Grab Intuitive Surgical While It's Cheap In advance of earnings let's take a look at how medical robotics maker Intuitive Surgical stacks up against some of its peers and competitors.  |
| <Older 5381-5390 Newer> Return to current articles. |